The research, funded by UK Research and Innovation's Engineering and Physical Sciences Research Council (UKRI-EPSRC), also explores the use of ultrasound for detecting subcutaneous gut pathologies. The device's sustainable design and cost-effectiveness make it viable for widespread adoption in healthcare settings. Dr. Cummins underscores the importance of affordability and scalability in medical technology development to ensure accessibility for patients.
A spinout company is being established to further develop the innovation, with a pending patent. Clinical testing is estimated to take at least five more years before the product is ready for market introduction. Heriot-Watt University's global research institute in health and care technologies aims to accelerate the adoption of innovative solutions in patient care, fostering collaboration between academia, industry, and healthcare providers.
MEDICA-tradefair.com; Source: Heriot-Watt University